[Value of combination therapy of pentalong (PETN) with obsidan (propranolol) in patients with coronary insufficiency].
D003327:Coronary Disease / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010417:Pentaerythritol Tetranitrate / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use*
D010417:Pentaerythritol Tetranitrate; D011433:Propranolol
Uber den Wert der Kombinationstherapie Pentalong (PETN) mit Obsidan (Propranolol) bei Patienten mit Koronarinsuffizienz